Amyotrophic lateral sclerosis and skeletal muscle: An update

Molecular Neurobiology

Volumn 49, Issue 2, 2014, Pages 984-990

  Pansarasa, O ^a   Rossi, D ^b   Berardinelli, A ^a   Cereda, C ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b IRCCS   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Mitochondria; Myogenic factors; Proteasome; Skeletal muscle fibres

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOGENIC FACTOR; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; PROTEASOME; TAR DNA BINDING PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR NFAT; UNCOUPLING PROTEIN 3;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; MOTONEURON; MUSCLE CELL; MUSCLE FUNCTION; NERVE DEGENERATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PROTEIN AGGREGATION; SKELETAL MUSCLE; ANIMAL; ASTROCYTE; METABOLISM; MITOCHONDRION; PATHOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; HUMANS; MITOCHONDRIA; MOTOR NEURONS; MUSCLE, SKELETAL;

EID: 84896543905     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8578-4     Document Type: Article

References (67)

1. Pette D, Staron RS (1990) Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116:1-76
2. Bottinelli R, Betto R, Schiaffino S, Reggiani C (1994) Maximum shortening velocity and coexistence of myosin heavy chain isoforms in single skinned fast fibres of rat skeletal muscle. J Muscle Res Cell Motil 15:413-419 (Pubitemid 24263449)
3. McCullagh KJ, Calabria E, Pallafacchina G, Ciciliot S, Serrano AL, Argentini C, Kalhovde JM, Lomo T, Schiaffino S (2004) NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl Acad Sci U S A 101:10590-10595 (Pubitemid 38955786)
4. Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287:C834-C843 (Pubitemid 39238306)
5. Boillée S, Velde CV, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59 (Pubitemid 44466358)
6. Bruijn L, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749 (Pubitemid 39050419)
7. Dobrowolny G, Aucello M, Rizzuto E et al (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8:425-436
8. Yamanaka K, Chun SJ, Boillée S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251-253 (Pubitemid 351311795)
9. Clement AM, Nguyen MD, Roberts EA et al (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-117, Erratum in: Science. 2003; 302:568 (Pubitemid 37210700)
10. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103:16021-16026 (Pubitemid 44657585)
11. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10:608-614 (Pubitemid 46652442)
12. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615-622 (Pubitemid 46652435)
13. Van Damme P, Bogaert E, Dewil M et al (2007) Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A 104:14825-14830 (Pubitemid 350003227)
14. Cassina P, Cassina A, Pehar M et al (2008) Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci 28:4115-4122
15. Rossi D, Brambilla L, Valori CF, Roncoroni C, Crugnola A, Yokota T, Bredesen DE, Volterra A (2008) Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ 15:1691-1700
16. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3:637-648
17. Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3:649-657
18. Díaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Martínez-Palma L, Cassina P, Beckman J, Barbeito L (2011) Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 108:18126-18131
19. Haidet-Phillips AM, Hester ME, Miranda CJ et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29:824-828
20. Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ (2011) Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A 108:17803-17808
21. Wang L, Gutmann DH, Roos RP (2011) Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet 20:286-293
22. Martorana F, Brambilla L, Valori CF, Bergamaschi C, Roncoroni C, Aronica E, Volterra A, Bezzi P, Rossi D (2012) The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum Mol Genet 21:826-840
23. Cova E, Cereda C, Galli A, Curti D, Finotti C, Di Poto C, Corato M, Mazzini G, Ceroni M (2006) Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett 399:186-190 (Pubitemid 44308127)
24. Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Rad Biol Med 48:629-641
25. Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762:1051-1067 (Pubitemid 44750575)
26. Ticozzi N, Tiloca C, Morelli C, Colombrita C, Poletti B, Doretti A, Maderna L, Messina S, Ratti A, Silani V (2011) Genetics of familial amyotrophic lateral sclerosis. Arch Ital Biol 149:65-82
27. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205-1208
28. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C (2007) TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 35:320-327 (Pubitemid 46843567)
29. Deng HX, Chen W, Hong ST et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ASL and ALS/dementia. Nature 477:211-215
30. Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in the C9ORF72 is the cause of the chromosome 9p21-linked ALS-FTD. Neuron 72:257-268
31. DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245-256
32. Wong M, Martin LJ (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 19:2284-2302
33. Da Cruz S, Parone PA, Lopes VS et al (2012) Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:778-786
34. Krivickas LS, Yang JI, Kim SK, Frontera WR (2002) Skeletal muscle fibre function and rate of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 26:636-643 (Pubitemid 35266087)
35. Hegedus J, Putman CT, Tyreman N, Gordon T (2008) Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586(14):3337-3351 (Pubitemid 352003870)
36. Hegedus J, Putman CT, Gordon T (2007) Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28:154-164 (Pubitemid 47615455)
37. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534-2542 (Pubitemid 30220340)
38. Schaefer AM, Sanes JR, Lichtman JW (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 490:209-219 (Pubitemid 41140989)
39. Derave W, Van Den Bosch L, Lemmens G, Eijnde BO, Robberecht W, Hespel P (2003) Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis 13:264-272 (Pubitemid 36937208)
40. Atkin JD, Scott RL, West JM, Lopes E, Quah AK, Cheema SS (2005) Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord 15:377-388
41. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120:11-19
42. Le Grand F, Rudnicki M (2007) Satellite and stem cells in muscle growth and repair. Development 134:3953-3957 (Pubitemid 350269412)
43. Buckingham M (2007) Skeletal muscle progenitor cells and the role of Pax genes. C R Biol 330:530-533
44. Asakura A, Komaki M, Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68:245-253 (Pubitemid 33754997)
45. Seale P, Rudnicki MA (2000) A new look at the origin, function, and 'stem-cell' status of muscle satellite cells. Dev Biol 218:115-124 (Pubitemid 30101962)
46. RudnickiMA, Le Grand F, McKinnel I, Kuang S (2008) The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 73:323-331
47. Manzano R, Toivonen JM, Olivan S, Calvo AC, Moreno-Igoa M, Muñoz MJ, Zaragoza P, García-Redondo A, Osta R (2011) Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 8:386-396
48. Manzano R, Toivonen JM, Calvo AC, Oliván S, Zaragoza P, Muñoz MJ, Montarras D, Osta R (2012) Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis. Stem Cell Rev 8:279-287
49. Manzano R, Toivonen JM, Calvo AC, Oliván S, Zaragoza P, Rodellar C, Montarras D, Osta R (2013) Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells. Neurodegener Dis 11:153-164
50. Dupuis L, Muller A, Meininger V, Loeffler JP (2004) Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models (in French). Rev Neurol (Paris) 160:35-43 (Pubitemid 38315598)
51. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806-819 (Pubitemid 33674062)
52. Afifi AK, Aleu FP, Goodgold J, MacKay B (1966) Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology 16:475-481
53. Sasaki S, Iwata M (1996) Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 204:53-56 (Pubitemid 26053674)
54. Chung MJ, Suh YL (2002) Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol 26:3-7
55. Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches E, Feistner H, Heinze HJ, Elger CE, Schubert W, Kunz WS (2000) Mitochondrial DNA abnormalities in skeletalmuscle of patients with sporadic amyotrophic lateral sclerosis. Brain 23:1339-1348 (Pubitemid 30420935)
56. Dupuis L, di Scala F, Rene F, de Tapia M, Oudart H, Pradat PF, Meininger V, Loeffler JP (2003) Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASAB J 17:2091-2093
57. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrère B, Couratier P (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74:328-334 (Pubitemid 32802018)
58. Beal MF (2000) Mitochondria and the pathogenesis of ALS. Brain 123:1291-1292
59. Vielhaber S, Kudin A, Winkler K, Wiedemann F, Schröder R, Feistner H, Heinze HJ, Elger CE, Kunz WS (2003) Is there mitochondrial dysfunction in ALS muscle? Ann Neurol 53:686-687
60. Echaniz-Laguna A, Zoll J, Ribera F, Tranchant C, Warter JM, Lonsdorfer J, Lampert E (2002) Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol 52:623-627 (Pubitemid 35246866)
61. Turner BJ, Lopes EC, Cheema SS (2003) Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse of familial amyotrophic lateral sclerosis. Neurosci Lett 350:132-136 (Pubitemid 37101429)
62. Wei R, Bhattacharya A, Chintalaramulu N, Jernigan AL, Liu Y, Van Remmen H, Chaudhuri AR (2012) Proteinmisfolding,mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS. Biochem Biophys Res Commun 417:1275-1279
63. Onesto E, Rusmini P, Crippa V, Ferri N, Zito A, Galbiati M, Poletti A (2011) Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. J Neurochem 118:266-280
64. Sau D, De Biasi S, Vitellaro-Zuccarello L et al (2007) Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mole Genet 16:1604-1618 (Pubitemid 47050674)
65. Cashman NR, Durham HD, Blusztajn JK, Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194:209-221
66. Sorarú G, Orsetti V, Buratti E, Baralle F, Cima V, Volpe M, D'Ascenzo C, Palmieri A, Koutsikos K, Pegoraro E, Angelini C (2010) TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:240-243
67. Hernandez Lain A, Millecamps S, Dubourg O et al (2011) Abnormal TDP-43 and FUS proteins inmuscles of sporadic IBM: similarities in a TARDBP-linked ALS patient. J Neurol Neurosurg Psychiatry 82:1414-1416